newsfilter
← Latest News
Business Wire·

CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

  • CAIRDAC, a pre-revenue medtech firm, appointed Raymond W. Cohen as chairman of its board of directors.
  • Cohen brings over four decades of experience, having co-founded & led Axonics to a $3.7 billion acquisition by Boston Scientific in late 2024.
  • In 2025, Cohen led the sale of SoniVie for $600 million & Nalu Medical for $533 million while serving as chairman of SoniVie.
  • Cohen currently serves on the boards of Kestra Medical Technologies & holds roles at Star51, Andera Partners, & Sherpa Capital Partners.
  • CAIRDAC is developing the Autonomous Leadless Pacing System (ALPS), which uses piezoelectric harvesters to convert heartbeat movement into electricity.
  • The ALPS technology aims to enable multi-chamber pacing, remote monitoring, & diagnostics by reducing reliance on conventional batteries.
  • The company plans a first-in-human study following 2026 preclinical results, targeting CE marking in Europe before a U.S. pivotal study.
  • Current investors include Mérieux Equity Partners, Supernova Invest, Bpifrance, Sham Innovation Santé, & Crédit Agricole Touraine et Poitou.
  • The device remains investigational & is not yet available for sale.